Codman Square Health Center, INC

Codman Square Health Center, INC was paid $8.55M by Medicaid between Sep 2018 and Dec 2024, across 46 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 59% of everything it billed.

33Billing provider infoCODMAN SQUARE HEALTH CENTER, INC
DORCHESTER, MA 02124

33aNPI1922599117assigned 05/23/2018

33bProvider typeUrgent Care Clinic/Center

28Total paid$8.55M

24GClaims127,578

24DCodes billed46

24AFirst – last monthSep 2018 – Dec 2024

Compared with peers

Next to other Urgent Care Clinic/Center providers in Massachusetts

Rank by total paid#1 of 117

Median peer was paid$225K

This provider vs. median38×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	4,682	$347K
2019	24,673	$1.81M
2020	16,518	$1.28M
2021	19,176	$1.51M
2022	25,591	$2.21M
2023	20,981	$884K
2024incomplete	15,957	$515K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	59%	56,269	53,563	$5.03M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	30%	24,221	23,410	$2.56M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.6%	1,801	1,731	$135K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	1.4%	803	800	$118K
99050		1.1%	6,339	6,220	$96K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	1.1%	994	913	$94K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	2,464	2,384	$74K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	2,438	2,358	$73K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	1,017	959	$57K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,799	1,729	$45K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	1,849	1,778	$43K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	<1%	357	355	$41K

34 more codes

99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	201	$26K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,023	$25K
81025		<1%	2,492	$16K
99204	Doctor's office visit, new patient (more involved)	<1%	377	$16K
87210		<1%	3,312	$15K
87220		<1%	3,273	$13K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	507	$11K
99051		<1%	2,514	$10K
86485		<1%	327	$8K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	879	$7K
80053	Comprehensive metabolic panel	<1%	629	$6K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	1,487	$6K
81003		<1%	2,591	$5K
86780		<1%	376	$5K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	2,299	$3K
90658		<1%	106	$3K
81001		<1%	943	$3K
86803		<1%	211	$3K
82962		<1%	1,025	$3K
T1015	A visit at a community health center or clinic (one all-in rate)	<1%	235	$1K
84443	Thyroid stimulating hormone (TSH)	<1%	77	$1K
82948		<1%	239	$1K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	552	$587.54
83036	Hemoglobin; glycosylated (A1C)	<1%	63	$560.55
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	162	$364.93
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	12	$84.74
80048	Basic metabolic panel (calcium, ionized)	<1%	12	$81.69
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	26	$1.98
A9150	Non-prescription drugs	0%	123	$0.00
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	0%	29	$0.00
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	0%	13	$0.00
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	0%	12	$0.00
71046	Radiologic examination, chest; 2 views	0%	87	$0.00
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWEAVER, TARSHA (CHIEF OPERATING OFFICER)

Parent organizationCODMAN SQUARE HEALTH CENTER